U.S. Markets closed

Rigel Pharmaceuticals, Inc. (RIGL)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
2.80+0.02 (+0.72%)
At close: 4:00PM EDT

2.80 0.00 (0.01%)
After hours: 5:10PM EDT

People also watch
Full screen
Previous Close2.78
Bid2.55 x 100
Ask2.95 x 100
Day's Range2.65 - 2.81
52 Week Range1.94 - 4.38
Avg. Volume1,015,954
Market Cap342.82M
PE Ratio (TTM)-4.18
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cubeyesterday

    Rigel Pharmaceuticals, Inc. – Value Analysis (NASDAQ:RIGL) : June 22, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Rigel Pharmaceuticals, Inc. a score of 18. Our analysis is based on comparing Rigel Pharmaceuticals, Inc. with the following peers – Chemocentryx, Inc., Infinity Pharmaceuticals, Inc., Innoviva, Inc., Windtree Therapeutics, Inc., Aradigm Corporation, Mylan N.V., Astrazeneca PLC Sponsored ADR, Acura Pharmaceuticals, Inc., Amgen Inc. and Sangamo Therapeutics, ... Read more (Read more...)

  • Rigel Pharmaceuticals' NDA for Tavalisse Accepted by FDA
    Zacks3 days ago

    Rigel Pharmaceuticals' NDA for Tavalisse Accepted by FDA

    Rigel Pharmaceuticals, Inc. (RIGL) announced that the FDA has accepted its new drug application (NDA) seeking approval for its oral spleen tyrosine kinase inhibitor, fostamatinib for the treatment of patients with chronic and persistent immune thrombocytopenia

  • Zacks3 days ago

    Company News for June 20, 2017

    Companies in the News are: RICE,EQT,RIGL,NVDQ,SYK,VRX